日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Investigating the role of mimosine-induced genotoxic stress through DNA repair profiling

通过DNA修复谱分析研究含羞草素诱导的基因毒性应激的作用

Pradeep, Sai Pallavi; Kalaria, Suraj; Glazer, Peter M; Bahal, Raman

Prenatal Intraportal Delivery of Polymeric Nanoparticles to Fetal Rhesus Monkeys (Macaca mulatta)

向恒河猴胎儿(Macaca mulatta)进行产前门静脉内聚合物纳米颗粒递送

Piotrowski-Daspit, Alexandra S; Lynn, Anna Y; Eaton, David A; Bracaglia, Laura G; Markey, Arianna I; Mortlock, Ryland D; Stitelman, David H; Martinez, Michele L; Lee, Charles C; Kliman, Harvey J; Glazer, Peter M; Tarantal, Alice F; Saltzman, W Mark

Correction: Harnessing ExDNA for precision Exatecan delivery in cancer: a novel antibody-drug conjugate approach

更正:利用ExDNA实现癌症中Exatecan的精准递送:一种新型抗体-药物偶联物方法

Ianniello, Zaira; Lu, Huimei; Quijano, Elias; Colón-Ríos, Daniel A; Rackear, Madison; Bommireddy, Venu; Ludwig, Dale L; Shen, Zhiyuan; Glazer, Peter M

Harnessing ExDNA for precision exatecan delivery in cancer: a novel antibody-drug conjugate approach.

利用 ExDNA 实现癌症中精准的依沙替康递送:一种新型抗体药物偶联物方法。

Ianniello Zaira, Lu Huimei, Quijano Elias, Colón-Ríos Daniel A, Rackear Madison, Bommireddy Venu, Ludwig Dale L, Shen Zhiyuan, Glazer Peter M

Hypoxia Induces Immunosuppression by Silencing STING in Cancer.

缺氧通过抑制癌细胞中的STING蛋白诱导免疫抑制。

Lu Yuhong, Yurkevicz Annali M, Liu Yanfeng, Glazer Peter M

Systemic administration of an RNA binding and cell-penetrating antibody targets therapeutic RNA to multiple mouse models of cancer.

系统性地施用一种 RNA 结合和细胞穿透抗体,将治疗性 RNA 靶向应用于多种小鼠癌症模型

Quijano Elias, Martinez-Saucedo Diana, Ianniello Zaira, Pinto-Medici Natasha, Rackear Madison, Chen Haoting, Lola-Pereira Luiz, Liu Yanfeng, Hegan Denise, Shan Xinning, Tseng Robert, Yugawa Deanne, Chowdhury Sumedha, Khang Minsoo, Singh Jay P, Abdullah Rashed, Azhir Perisa, Kashima Soki, Woods Wendy S, Gosstola Nicholas, Turner Bruce C, Squinto Stephen, Ludwig Dale L, Bindra Ranjit S, Robert Marie E, Braun David A, Perez Pinera Pablo, Saltzman W Mark, Escobar-Hoyos Luisa F, Glazer Peter M

Systemic in utero gene editing as a treatment for cystic fibrosis

系统性子宫内基因编辑作为囊性纤维化的治疗方法

Ricciardi, Adele S; Barone, Christina; Putman, Rachael; Quijano, Elias; Gupta, Anisha; Nguyen, Richard; Mandl, Hanna; Piotrowski-Daspit, Alexandra S; Lopez-Giraldez, Francesc; Luks, Valerie; Freedman-Weiss, Mollie R; Farrelly, James; Ahle, Samantha; Lynn, Anna Y; Glazer, Peter M; Saltzman, W Mark; Stitelman, David H; Egan, Marie E

Cell-penetrating antibody enhances nuclear delivery of triplex-forming oligonucleotides targeting HER2-positive cancers

细胞穿透抗体增强靶向HER2阳性癌症的三链寡核苷酸的核递送

Minnah, Anthony; García Tubéns, Nicole M; Krysztofiak, Adam; Liu, Yanfeng; Glazer, Peter M; Rogers, Faye A

Next generation triplex-forming PNAs for site-specific genome editing of the F508del CFTR mutation

用于F508del CFTR突变位点特异性基因组编辑的新一代三链体形成PNA

Gupta, Anisha; Barone, Christina; Quijano, Elias; Piotrowski-Daspit, Alexandra S; Perera, J Dinithi; Riccardi, Adele; Jamali, Haya; Turchick, Audrey; Zao, Weixi; Saltzman, W Mark; Glazer, Peter M; Egan, Marie E

PARP inhibitor resistance in IDH1-mutant cancers due to loss of end protection factors, 53BP1 and REV7.

IDH1 突变癌症中 PARP 抑制剂耐药性是由于末端保护因子 53BP1 和 REV7 的缺失所致。

Colón-Ríos Daniel Andrés, Dow Jonathan, Krysztofiak Adam, Liu Yanfeng, Rogers Faye A, Glazer Peter M